A nurse is conducting a comprehensive assessment of a newly admitted client. The nurse has read in the client's medical record that she has a diagnosis of metabolic syndrome. What assessment finding is consistent with this diagnosis?
A) The client has respiratory wheeze that is consistent with asthma.
B) The client has edema present in her feet and ankles.
C) The client's resting heart rate is 90 beats per minute
D) The client's blood pressure is 151/92 mmHg.
D
Feedback:
Metabolic syndrome is characterized by obesity, abdominal fat, hypertension, and elevated blood glucose (insulin resistance) and fat levels. Respiratory problems, heart rate, and edema are not components of a diagnosis of metabolic syndrome.
You might also like to view...
The nurse is preparing to draw blood on a client who is suspected of having systemic lupus erythematosus (SLE). Before obtaining the specimen, the nurse should ask the client which question?
1. "How long have you had symptoms?" 2. "Are you taking oral contraceptives?" 3. "Does SLE run in your family?" 4. "Are you experiencing pain?"
The nurse is providing patient education to a 26-year-old college student who is being treated for Trichomonas vaginalis with metronidazole (Flagyl). Which statement by the patient indicates understanding of the teaching?
a. "I should not consume alcohol while taking this medication." b. "If I have dark urine, I should stop taking the drug." c. "The drug is safe throughout pregnancy." d. "Vertigo and headaches may occur and are signs of toxicity."
Brian is experiencing abdominal distention after a recent surgery. Which of the following drugs should Brian's physician prescribe?
A. Dinoprostone B. Methylergonovine C. Oxytocin D. Desmopressin
In the context of the drugs used to treat bone disorders, which of the following is true of bisphosphonates?
A. Bisphosphonates are used to stimulate bone resorption in men and women. B. Bisphosphonates are analogs of endogenous pyrophosphates that have a special attraction to calcium in bones. C. Bisphosphonates are well absorbed by the gastrointestinal tract. D. The nitrogen-bisphosphonates have lesser resorption inhibition potency than non-nitrogen bisphosphonates.